Knight Therapeutics Inc (GUD_TSE) earnings
Quarterly and annual GUD_TSE reports and results, each read against the price at its own news timestamp. Back to the GUD_TSE overview →
18 measured GUD_TSE earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Knight Therapeutics Reports Second Quarter 2026 Results | Press release | — | — | |
| Notice of Knight Therapeutics' Second Quarter 2026 Results Conference Call | Press release | — | — | |
| Knight Therapeutics Reports First Quarter 2026 Results | Press release | — | — | |
| Notice of Knight Therapeutics' First Quarter 2026 Results Conference Call | Press release | — | — | |
| Knight Therapeutics Reports Third Quarter 2025 Results | Press release | — | — | |
| Notice of Knight Therapeutics' Third Quarter 2025 Results Conference Call | Press release | — | — | |
| Knight Therapeutics Reports Second Quarter 2025 Results | Press release | — | — | |
| Notice of Knight Therapeutics' Second Quarter 2025 Results Conference Call | Press release | — | — | |
| Knight Therapeutics Reports First Quarter 2025 Results | Press release | — | — | |
| Notice of Knight Therapeutics' First Quarter 2025 Results Conference Call | Press release | — | — | |
| Knight Therapeutics Reports Third Quarter 2024 | Press release | — | — | |
| Notice of Knight Therapeutics' Third Quarter 2024 Results Conference Call | Press release | — | — | |
| Knight Therapeutics Reports Second Quarter 2024 | Press release | +0.00% | +2.31% | |
| Notice of Knight Therapeutics' Second Quarter 2024 Results Conference Call | Press release | +0.18% | +0.35% | |
| Knight Therapeutics Reports First Quarter 2024 Results | Press release | +0.17% | +3.39% | |
| Notice of Knight Therapeutics' First Quarter 2024 Results Conference Call | Press release | +0.69% | +0.69% | |
| Knight Therapeutics Reports Third Quarter 2023 Results | Press release | +2.30% | +4.17% | |
| Notice of Knight Therapeutics' Third Quarter 2023 Results Conference Call | Press release | +0.43% | -0.43% |
Keep exploring
More GUD_TSE: analyst actions → · SEC filings → · GUD_TSE overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NUO THERAPEUTICS INC NEW (AURX) | 84 | 0.00% | 24% |
| Eloxx Pharmaceuticals, Inc. (ELOX) | 84 | 0.00% | 14% |
| Molecular Templates, Inc. (MTEM) | 84 | -0.48% | 39% |
| PharmaCyte Biotech, Inc. (PMCB) | 84 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.